The Neuroscience:Translate grant program supports research projects at the intersection of biology, engineering and medicine to address practical unmet needs in brain health and the neurosciences.
The program funds cross-disciplinary teams to develop new devices, diagnostic procedures, software, pharmaceutical therapies and other products that can be brought rapidly to market through new startup companies or partnerships with existing entities. Grants of $100,000-$120,000 are awarded annually to approximately three teams. Teams who have previously received Neuroscience:Translate awards may apply for a one-year renewal to continue advancing their technology.
This program was inspired by the successful Stanford Coulter Translational Research program, a partnership between Stanford Bioengineering and the Coulter Foundation managed by the Stanford Mussallem Center for Biodesign. The Wu Tsai Neurosciences Institute has partnered with Stanford Biodesign to bring this same approach and expertise to bear on the field of neuroscience and brain diseases, with guidance from a Neuroscience:Translate oversight committee comprising scientific and industry leaders in health technology development.
No-cost extensions
No-Cost Extension requests may be granted upon application. Applications will be strictly reviewed for compliance with the award deliverables and project. Applications are due one month prior to the award end date by downloading, completing, saving, and submitting the linked form template.
Questions? Contact Program Manager, Linda Lucian: llucian@stanford.edu.
Apply for Neuroscience:Translate by November 11
Applications open on Friday, September 20, 2024 and close on Monday, November 11, 2024 at 11:59 PM. Make sure to read the full application and eligibility criteria before submitting your application.
Application and Eligibility Criteria
Funded Neuroscience:Translate projects
Rapid and automated educational assessment through the web browser
Multi-modal deep learning for automated seizure localization
Developing an automated seizure detection and localization system based on deep neural networks, EEG data, and real-time video with the goal to dramatically increase neurologist diagnostic capabilities while improving quality of care.
Development and validation of selective novel small molecule therapeutics for Parkinson's Disease
New Thrombectomy Device for Endovascular Neurosurgery
This team will use their Neuroscience:Translate award to develop an entirely new class of ischemic stroke treatment device that will lead to improved clot extraction to improve the success of endovascular thrombectomy.
The wearable ENG: A dizzy attack event monitor
Optimization of the African killifish platform for rapid drug screening for aggregate based neurodegenerative diseases
The rehab glove: Passive tactile stimulation for stroke rehabilitation
Project's stimulation method may provide a powerful tool to reduce disability after a stroke, and the wearable form factor allows users to receive intensive therapy during their normal daily routine